United States Biotechnology & Medical Research

Recursion Pharmaceuticals Inc (RXRX)

Track

Over the past 90 days, Recursion Pharmaceuticals Inc. has seen 38 insider trading transactions, all involving sales totaling approximately $9.66 million. Former Director Christopher Gibson accounted for the majority of these divestments. These transactions occurred amid a 22.5% decline in stock price, following the company's May 2026 earnings report.
Ticker: RXRX Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Recursion Pharmaceuticals Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Gibson Christopher
Former Director
1 sale — total 100,000 USD
Proposed sale 21 Jul 2026
Value US$4,670,944.39 | Price 356.99 | Shares 38,850
Proposed sale 20 Jul 2026
Value US$275,615.42 | Price 165.29 | Shares 38,653
Proposed sale 17 Jul 2026
Value US$100,000.00 | Price 2.97 | Shares 1,000
Proposed sale 16 Jul 2026
Value US$100,000.00 | Price 3.11 | Shares 1,000
Proposed sale 15 Jul 2026
Value US$100,000.00 | Price 3.33 | Shares 1,000
Proposed sale 14 Jul 2026
Value US$100,000.00 | Price 3.30 | Shares 1,000
Proposed sale 13 Jul 2026
Value US$100,000.00 | Price 3.43 | Shares 1,000
Proposed sale 10 Jul 2026
Value US$100,000.00 | Price 3.54 | Shares 1,000
Proposed sale 9 Jul 2026
Value US$100,000.00 | Price 3.80 | Shares 1,000
Proposed sale 8 Jul 2026
Value US$100,000.00 | Price 3.69 | Shares 1,000
Planned sale 7 Jul 2026
Value US$100,000.00 | Price 3.96 | Shares 1,000
Proposed sale 7 Jul 2026
Value US$100,000.00 | Price 3.96 | Shares 1,000
Proposed sale 7 Jul 2026
Value US$100,000.00 | Price 3.95 | Shares 1,000
Proposed sale 6 Jul 2026
Value US$100,000.00 | Price 3.78 | Shares 1,000
Proposed sale 2 Jul 2026
Value US$100,000.00 | Price 3.75 | Shares 1,000
Proposed sale 1 Jul 2026
Value US$100,000.00 | Price 3.67 | Shares 1,000
Planned sale 18 Jun 2026
Value US$12,602.34 | Price 3.18 | Shares 3,963
Proposed sale 18 Jun 2026
Value US$12,602.34 | Price 3.18 | Shares 3,963
Proposed sale 18 Jun 2026
Value US$12,602.34 | Price 3.18 | Shares 3,963
Proposed sale 18 Jun 2026
Value US$962,341.29 | Price 3.20 | Shares 300,440
Proposed sale 18 Jun 2026
Value US$127,200.00 | Price 3.18 | Shares 40,000
Planned sale 5 Jun 2026
Value US$84,459.19 | Price 3.58 | Shares 23,588
Planned sale 5 Jun 2026
Value US$84,459.19 | Price 3.58 | Shares 23,588
Planned sale 5 Jun 2026
Value US$144,800.00 | Price 3.62 | Shares 40,000
Planned sale 5 Jun 2026
Value US$144,800.00 | Price 3.62 | Shares 40,000
Proposed sale 5 Jun 2026
Value US$144,800.00 | Price 3.62 | Shares 40,000
Proposed sale 5 Jun 2026
Value US$84,459.20 | Price 3.58 | Shares 23,588
Planned sale 3 Jun 2026
Value US$15,526.44 | Price 3.54 | Shares 4,386
Proposed sale 3 Jun 2026
Value US$15,526.44 | Price 3.54 | Shares 4,386
Planned sale 2 Jun 2026
Value US$110,400.00 | Price 3.68 | Shares 30,000
Proposed sale 2 Jun 2026
Value US$110,400.00 | Price 3.68 | Shares 30,000
Planned sale 22 May 2026
Value US$123,200.00 | Price 3.08 | Shares 40,000
Proposed sale 22 May 2026
Value US$123,200.00 | Price 3.08 | Shares 40,000
Planned sale 7 May 2026
Value US$134,800.00 | Price 3.37 | Shares 40,000
Proposed sale 7 May 2026
Value US$134,800.00 | Price 3.37 | Shares 40,000
Planned sale 5 May 2026
Value US$105,600.00 | Price 3.52 | Shares 30,000
Proposed sale 5 May 2026
Value US$105,600.00 | Price 3.52 | Shares 30,000
Planned sale 22 Apr 2026
Value US$144,400.00 | Price 3.61 | Shares 40,000
Proposed sale 22 Apr 2026
Value US$144,400.00 | Price 3.61 | Shares 40,000
Planned sale 7 Apr 2026
Value US$93,000.00 | Price 3.10 | Shares 30,000
Proposed sale 7 Apr 2026
Value US$93,000.00 | Price 3.10 | Shares 30,000
Planned sale 7 Apr 2026
Value US$124,000.00 | Price 3.10 | Shares 40,000
Proposed sale 7 Apr 2026
Value US$124,000.00 | Price 3.10 | Shares 40,000
Planned sale 23 Mar 2026
Value US$130,000.00 | Price 3.25 | Shares 40,000
Proposed sale 23 Mar 2026
Value US$130,000.00 | Price 3.25 | Shares 40,000
Planned sale 17 Mar 2026
Value US$26,970.84 | Price 3.39 | Shares 7,956
Proposed sale 17 Mar 2026
Value US$26,970.84 | Price 3.39 | Shares 7,956
Planned sale 9 Mar 2026
Value US$94,659.64 | Price 3.35 | Shares 28,298
Proposed sale 9 Mar 2026
Value US$94,662.47 | Price 3.35 | Shares 28,298
Sale 3 Mar 2026
Value US$588,200.00 | Price 3.46 | Shares 170,000
Proposed sale 3 Mar 2026
Value US$588,200.00 | Price 3.46 | Shares 170,000
Planned sale 19 Feb 2026
Value US$138,400.00 | Price 3.46 | Shares 40,000
Proposed sale 19 Feb 2026
Value US$138,400.00 | Price 3.46 | Shares 40,000
Planned sale 18 Feb 2026
Value US$41,352.08 | Price 3.08 | Shares 13,426
Proposed sale 18 Feb 2026
Value US$41,352.08 | Price 3.08 | Shares 13,426
Planned sale 4 Feb 2026
Value US$164,800.00 | Price 4.12 | Shares 40,000
Proposed sale 4 Feb 2026
Value US$164,800.00 | Price 4.12 | Shares 40,000
Planned sale 3 Feb 2026
Value US$924,000.00 | Price 4.20 | Shares 220,000
Proposed sale 3 Feb 2026
Value US$924,000.00 | Price 4.20 | Shares 220,000
Planned sale 20 Jan 2026
Value US$178,800.00 | Price 4.47 | Shares 40,000
Proposed sale 20 Jan 2026
Value US$178,800.00 | Price 4.47 | Shares 40,000
Planned sale 6 Jan 2026
Value US$959,200.00 | Price 4.36 | Shares 220,000
Proposed sale 6 Jan 2026
Value US$959,200.00 | Price 4.36 | Shares 220,000
Planned sale 5 Jan 2026
Value US$170,000.00 | Price 4.25 | Shares 40,000
Proposed sale 5 Jan 2026
Value US$170,000.00 | Price 4.25 | Shares 40,000
Planned sale 29 Dec 2025
Value US$89,380.94 | Price 4.18 | Shares 21,383
Proposed sale 29 Dec 2025
Value US$89,380.94 | Price 4.18 | Shares 21,383
Planned sale 22 Dec 2025
Value US$548,592.35 | Price 4.41 | Shares 124,403
Proposed sale 22 Dec 2025
Value US$548,587.96 | Price 4.41 | Shares 124,403
Proposed sale 19 Dec 2025
Value US$180,000.00 | Price 4.50 | Shares 40,000
Planned sale 19 Dec 2025
Value US$180,000.00 | Price 4.50 | Shares 40,000
Planned sale 4 Dec 2025
Value US$185,200.00 | Price 4.63 | Shares 40,000
Proposed sale 4 Dec 2025
Value US$185,200.00 | Price 4.63 | Shares 40,000
Planned sale 2 Dec 2025
Value US$961,400.00 | Price 4.37 | Shares 220,000
Proposed sale 2 Dec 2025
Value US$961,400.00 | Price 4.37 | Shares 220,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-21 2026-07-21 PrS Proposed sale
3.5
Gibson Christopher

Former Director

Non-Executive Director
38,850
356.99
US$4,670,944 		38,850 356.99 US$4,670,944
2026-07-20 2026-07-20 PrS Proposed sale
3.5
Gibson Christopher

Former Director

Non-Executive Director
38,653
165.29
US$275,615 		38,653 165.29 US$275,615
2026-07-17 2026-07-17 PrS Proposed sale
3.5
Gibson Christopher

Former Director

Non-Executive Director
1,275
164.75
US$3,367,456 		1,275 164.75 US$3,367,456
2026-07-16 2026-07-16 PrS Proposed sale
3.5
Gibson Christopher

Former Director

Non-Executive Director
1,000
3.11
US$100,000 		1,000 3.11 US$100,000
2026-07-15 2026-07-15 PrS Proposed sale
3.5
Gibson Christopher

Former Director

Non-Executive Director
1,000
3.33
US$100,000 		1,000 3.33 US$100,000
2026-07-14 2026-07-14 PrS Proposed sale
3.5
Gibson Christopher

Former Director

Non-Executive Director
1,000
3.30
US$100,000 		1,000 3.30 US$100,000
2026-07-13 2026-07-13 PrS Proposed sale
3.5
Gibson Christopher

Former Director

Non-Executive Director
1,000
3.43
US$100,000 		1,000 3.43 US$100,000
2026-07-10 2026-07-10 PrS Proposed sale
3.5
Gibson Christopher

Former Director

Non-Executive Director
1,000
3.54
US$100,000 		1,000 3.54 US$100,000
2026-07-09 2026-07-09 PrS Proposed sale
3.5
Gibson Christopher

Former Director

Non-Executive Director
1,000
3.80
US$100,000 		1,000 3.80 US$100,000
2026-07-08 2026-07-08 PrS Proposed sale
3.5
Gibson Christopher

Former Director

Non-Executive Director
1,000
3.69
US$100,000 		1,000 3.69 US$100,000
2026-07-09 2026-07-07 PlS Planned sale
1.6
Borgeson Blake
Non-Executive Director
1,000 -0.6%
3.96
US$100,000 		1,000 -0.6% 3.96 US$100,000
2026-07-07 2026-07-07 PrS Proposed sale
3.5
Gibson Christopher

Former Director

Non-Executive Director
1,000
3.95
US$100,000 		1,000 3.95 US$100,000
2026-07-07 2026-07-07 PrS Proposed sale
1.6
Borgeson Blake

Director

Non-Executive Director
1,000
3.96
US$100,000 		1,000 3.96 US$100,000
2026-07-06 2026-07-06 PrS Proposed sale
3.5
Gibson Christopher

Former Director

Non-Executive Director
1,000
3.78
US$100,000 		1,000 3.78 US$100,000
2026-07-02 2026-07-02 PrS Proposed sale
3.5
Gibson Christopher

Former Director

Non-Executive Director
1,000
3.75
US$100,000 		1,000 3.75 US$100,000
2026-07-01 2026-07-01 PrS Proposed sale
3.5
Gibson Christopher

Former Director

Non-Executive Director
1,000
3.67
US$100,000 		1,000 3.67 US$100,000
2026-06-22 2026-06-18 PlS Planned sale
Bumpus Namandje
Non-Executive Director
3,963 -3.0%
3.18
US$12,602 		3,963 -3.0% 3.18 US$12,602
2026-06-18 2026-06-18 PrS Proposed sale
3.5
Gibson Christopher

Director

Non-Executive Director
300,440
3.20
US$962,341 		300,440 3.20 US$962,341
2026-06-18 2026-06-18 PrS Proposed sale
Bumpus Namandje

Director

Non-Executive Director
3,963
3.18
US$12,602 		3,963 3.18 US$12,602
2026-06-18 2026-06-18 PrS Proposed sale
Bumpus Namandje

Director

Non-Executive Director
3,963
3.18
US$12,602 		3,963 3.18 US$12,602
2026-06-18 2026-06-18 PrS Proposed sale
3.5
Gibson Christopher

Director

Non-Executive Director
40,000
3.18
US$127,200 		40,000 3.18 US$127,200
2026-06-05 2026-06-05 PlS Planned sale
3.2
Khan Najat

CEO and President

Executive Director
23,588 -1.1%
3.58
US$84,459 		23,588 -1.1% 3.58 US$84,459
2026-06-05 2026-06-05 PlS Planned sale
3.2
Khan Najat

CEO and President

Executive Director
23,588 -1.1%
3.58
US$84,459 		23,588 -1.1% 3.58 US$84,459
2026-06-05 2026-06-05 PlS Planned sale
3.5
Gibson Christopher
Non-Executive Director
40,000 -4.3%
3.62
US$144,800 		40,000 -4.3% 3.62 US$144,800
2026-06-05 2026-06-05 PlS Planned sale
3.5
Gibson Christopher
Non-Executive Director
40,000 -4.3%
3.62
US$144,800 		40,000 -4.3% 3.62 US$144,800
2026-06-05 2026-06-05 PrS Proposed sale
3.2
Najat Khan

Officer

Officer
23,588
3.58
US$84,459 		23,588 3.58 US$84,459
2026-06-05 2026-06-05 PrS Proposed sale
3.5
Gibson Christopher

Director

Non-Executive Director
40,000
3.62
US$144,800 		40,000 3.62 US$144,800
2026-06-04 2026-06-03 PlS Planned sale
Bumpus Namandje
Non-Executive Director
4,386 -9.2%
3.54
US$15,526 		4,386 -9.2% 3.54 US$15,526
2026-06-03 2026-06-03 PrS Proposed sale
Bumpus Namandje

Director

Non-Executive Director
4,386
3.54
US$15,526 		4,386 3.54 US$15,526
2026-06-04 2026-06-02 PlS Planned sale
1.6
Borgeson Blake
Non-Executive Director
30,000 -0.5%
3.68
US$110,400 		30,000 -0.5% 3.68 US$110,400
2026-06-02 2026-06-02 PrS Proposed sale
1.6
Borgeson Blake

Director

Non-Executive Director
30,000
3.68
US$110,400 		30,000 3.68 US$110,400
2026-05-27 2026-05-22 PlS Planned sale
3.5
Gibson Christopher
Non-Executive Director
40,000 -4.3%
3.08
US$123,200 		40,000 -4.3% 3.08 US$123,200
2026-05-22 2026-05-22 PrS Proposed sale
3.5
Gibson Christopher

Director

Non-Executive Director
40,000
3.08
US$123,200 		40,000 3.08 US$123,200
2026-05-08 2026-05-07 PlS Planned sale
3.5
Gibson Christopher
Non-Executive Director
40,000 -4.1%
3.37
US$134,800 		40,000 -4.1% 3.37 US$134,800
2026-05-07 2026-05-07 PrS Proposed sale
3.5
Gibson Christopher

Director

Non-Executive Director
40,000
3.37
US$134,800 		40,000 3.37 US$134,800
2026-05-07 2026-05-05 PlS Planned sale
1.6
Borgeson Blake
Non-Executive Director
30,000 -0.5%
3.52
US$105,600 		30,000 -0.5% 3.52 US$105,600
2026-05-05 2026-05-05 PrS Proposed sale
1.6
Borgeson Blake

Director

Non-Executive Director
30,000
3.52
US$105,600 		30,000 3.52 US$105,600
2026-04-24 2026-04-22 PlS Planned sale
3.5
Gibson Christopher
Non-Executive Director
40,000 -4.2%
3.61
US$144,400 		40,000 -4.2% 3.61 US$144,400
2026-04-22 2026-04-22 PrS Proposed sale
3.5
Gibson Christopher

Director

Non-Executive Director
40,000
3.61
US$144,400 		40,000 3.61 US$144,400
2026-04-08 2026-04-07 PlS Planned sale
1.6
Borgeson Blake
Non-Executive Director
30,000 -0.5%
3.10
US$93,000 		30,000 -0.5% 3.10 US$93,000
2026-04-08 2026-04-07 PlS Planned sale
3.5
Gibson Christopher
Non-Executive Director
40,000 -4.2%
3.10
US$124,000 		40,000 -4.2% 3.10 US$124,000
2026-04-07 2026-04-07 PrS Proposed sale
3.5
Gibson Christopher

Director

Non-Executive Director
40,000
3.10
US$124,000 		40,000 3.10 US$124,000
2026-04-07 2026-04-07 PrS Proposed sale
1.6
Borgeson Blake

Director

Non-Executive Director
30,000
3.10
US$93,000 		30,000 3.10 US$93,000
2026-03-25 2026-03-23 PlS Planned sale
3.5
Gibson Christopher
Non-Executive Director
40,000 -4.2%
3.25
US$130,000 		40,000 -4.2% 3.25 US$130,000
2026-03-23 2026-03-23 PrS Proposed sale
3.5
Gibson Christopher

Director

Non-Executive Director
40,000
3.25
US$130,000 		40,000 3.25 US$130,000
2026-03-18 2026-03-17 PlS Planned sale
3.3
Taylor Ben R

Chief Financial Officer

Officer
7,956 -0.7%
3.39
US$26,971 		7,956 -0.7% 3.39 US$26,971
2026-03-17 2026-03-17 PrS Proposed sale
3.3
Taylor Ben R

Officer

Officer
7,956
3.39
US$26,971 		7,956 3.39 US$26,971
2026-03-11 2026-03-09 PlS Planned sale
3.2
Khan Najat

CEO and President

Executive Director
28,298 -1.2%
3.35
US$94,660 		28,298 -1.2% 3.35 US$94,660
2026-03-09 2026-03-09 PrS Proposed sale
3.2
Najat Khan

Officer

Officer
28,298
3.35
US$94,662 		28,298 3.35 US$94,662
2026-03-04 2026-03-03 S Sale
1.6
Borgeson Blake
Non-Executive Director
170,000 -2.6%
3.46
US$588,200 		170,000 -2.6% 3.46 US$588,200
2026-03-03 2026-03-03 PrS Proposed sale
1.6
Borgeson Blake

Director

Non-Executive Director
170,000
3.46
US$588,200 		170,000 3.46 US$588,200
2026-02-19 2026-02-19 PlS Planned sale
3.5
Gibson Christopher
Non-Executive Director
40,000 -4.2%
3.46
US$138,400 		40,000 -4.2% 3.46 US$138,400
2026-02-19 2026-02-19 PrS Proposed sale
3.5
Gibson Christopher

Director

Non-Executive Director
40,000
3.46
US$138,400 		40,000 3.46 US$138,400
2026-02-19 2026-02-18 PlS Planned sale
3.3
Taylor Ben R

Chief Financial Officer

Officer
13,426 -1.1%
3.08
US$41,352 		13,426 -1.1% 3.08 US$41,352
2026-02-18 2026-02-18 PrS Proposed sale
3.3
Taylor Ben R

Officer

Officer
13,426
3.08
US$41,352 		13,426 3.08 US$41,352
2026-02-06 2026-02-04 PlS Planned sale
3.5
Gibson Christopher
Non-Executive Director
40,000 -4.2%
4.12
US$164,800 		40,000 -4.2% 4.12 US$164,800
2026-02-04 2026-02-04 PrS Proposed sale
3.5
Gibson Christopher

Director

Non-Executive Director
40,000
4.12
US$164,800 		40,000 4.12 US$164,800
2026-02-06 2026-02-03 PlS Planned sale
1.6
Borgeson Blake
Non-Executive Director
220,000 -3.3%
4.20
US$924,000 		220,000 -3.3% 4.20 US$924,000
2026-02-03 2026-02-03 PrS Proposed sale
1.6
Borgeson Blake

Director

Non-Executive Director
220,000
4.20
US$924,000 		220,000 4.20 US$924,000
2026-01-22 2026-01-20 PlS Planned sale
3.5
Gibson Christopher
Non-Executive Director
40,000 -4.2%
4.47
US$178,800 		40,000 -4.2% 4.47 US$178,800
2026-01-20 2026-01-20 PrS Proposed sale
3.5
Gibson Christopher

Director

Non-Executive Director
40,000
4.47
US$178,800 		40,000 4.47 US$178,800
2026-01-08 2026-01-06 PlS Planned sale
1.6
Borgeson Blake
Non-Executive Director
220,000 -3.2%
4.36
US$959,200 		220,000 -3.2% 4.36 US$959,200
2026-01-06 2026-01-06 PrS Proposed sale
1.6
Borgeson Blake

Director

Non-Executive Director
220,000
4.36
US$959,200 		220,000 4.36 US$959,200
2026-01-07 2026-01-05 PlS Planned sale
3.5
Gibson Christopher
Non-Executive Director
40,000 -4.1%
4.25
US$170,000 		40,000 -4.1% 4.25 US$170,000
2026-01-05 2026-01-05 PrS Proposed sale
3.5
Gibson Christopher

Director

Non-Executive Director
40,000
4.25
US$170,000 		40,000 4.25 US$170,000
2025-12-30 2025-12-29 PlS Planned sale
3.3
Taylor Ben R

Chief Financial Officer

Officer
21,383 -2.7%
4.18
US$89,381 		21,383 -2.7% 4.18 US$89,381
2025-12-29 2025-12-29 PrS Proposed sale
3.3
Taylor Ben R

Officer

Officer
21,383
4.18
US$89,381 		21,383 4.18 US$89,381
2025-12-29 2025-12-22 PlS Planned sale
3.2
Khan Najat

Chief R&D Commercial Officer

Executive Director
124,403 -16.9%
4.41
US$548,592 		124,403 -16.9% 4.41 US$548,592
2025-12-22 2025-12-22 PrS Proposed sale
3.2
Najat Khan

Officer

Officer
124,403
4.41
US$548,588 		124,403 4.41 US$548,588
2025-12-19 2025-12-19 PrS Proposed sale
3.5
Gibson Christopher

Officer; Director

Executive Director
40,000
4.50
US$180,000 		40,000 4.50 US$180,000
2025-12-19 2025-12-19 PlS Planned sale
3.5
Gibson Christopher

Chief Executive Officer

Executive Director
40,000 -4.2%
4.50
US$180,000 		40,000 -4.2% 4.50 US$180,000
2025-12-05 2025-12-04 PlS Planned sale
3.5
Gibson Christopher

Chief Executive Officer

Executive Director
40,000 -4.1%
4.63
US$185,200 		40,000 -4.1% 4.63 US$185,200
2025-12-04 2025-12-04 PrS Proposed sale
3.5
Gibson Christopher

Officer; Director

Executive Director
40,000
4.63
US$185,200 		40,000 4.63 US$185,200
2025-12-04 2025-12-02 PlS Planned sale
1.6
Borgeson Blake
Non-Executive Director
220,000 -3.1%
4.37
US$961,400 		220,000 -3.1% 4.37 US$961,400
2025-12-02 2025-12-02 PrS Proposed sale
1.6
Borgeson Blake

Director

Non-Executive Director
220,000
4.37
US$961,400 		220,000 4.37 US$961,400
Explore more

More insider trading research around Recursion Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America